Men with a shorter membranous urethra appear more likely to experience urinary incontinence after laser enucleation for ...
Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two "trial in progress" presentations at the 2026 European Association of Urology congress (EAU) in London, UK. These trials investigate ...
Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...
The Urocross® Expander System is designed to remodel the obstructing prostatic lobes during the six-month indwell time and is ...
Large international study finds nearly half of patients admitted with visible blood in urine receive no imaging, delaying ...
One in ten patients who attend A&E after noticing blood in their urine die within three months, new research has revealed.
One in ten emergency patients with visible blood in their urine dies within three months of presenting at hospital emergency ...
Bladder Pain Syndrome is believed to arise from bladder wall hypersensitivity and disruption of its protective lining, ...
Dr. Alexandre Zlotta delivered the State-of-the-art lecture Who really needs surgery after neo-adjuvant chemotherapy? Dr.
One in ten emergency patients with visible blood in their urine die within three months of presenting at A&E, new research ...
India, March 17 -- Latest study shows a serious link between emergency room wait times and patient survival. One in ten ...
Patients in A&E who are offered scans and investigations within 48 hours have far better chances of survival, study finds ...